SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-336446
Filing Date
2017-11-08
Accepted
2017-11-08 07:01:51
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d463715d10q.htm 10-Q 270460
2 EX-3.1 d463715dex31.htm EX-3.1 6072
3 EX-3.2 d463715dex32.htm EX-3.2 6068
4 EX-31.1 d463715dex311.htm EX-31.1 6003
5 EX-32.1 d463715dex321.htm EX-32.1 3162
  Complete submission text file 0001193125-17-336446.txt   2042077

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxii-20170930.xml EX-101.INS 312301
7 XBRL TAXONOMY EXTENSION SCHEMA rxii-20170930.xsd EX-101.SCH 26380
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20170930_cal.xml EX-101.CAL 35980
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20170930_def.xml EX-101.DEF 108649
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20170930_lab.xml EX-101.LAB 227404
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20170930_pre.xml EX-101.PRE 166531
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 171185032
SIC: 2834 Pharmaceutical Preparations